Your browser doesn't support javascript.
loading
A Review of Complications Due to the Use of Botulinum Toxin A for Cosmetic Indications.
Sethi, Nitin; Singh, Sukhbir; DeBoulle, Koenraad; Rahman, Eqram.
Afiliação
  • Sethi N; Plastic and Cosmetic Surgery, Fortis Hospital Ludhiana, Punjab, 141001, India. drnitinsethi@gmail.com.
  • Singh S; Resplendent the Cosmetic Studio, R-9, GK-1, New Delhi, 110048, India.
  • DeBoulle K; Aalst Dermatology Clinic, Aalst, Belgium.
  • Rahman E; Department of Plastic and Reconstructive Surgery, University College London and Royal Fre Hospital, Hampstead, London, NW3 2QG, UK.
Aesthetic Plast Surg ; 45(3): 1210-1220, 2021 06.
Article em En | MEDLINE | ID: mdl-33051718
ABSTRACT

BACKGROUND:

Botulinum toxin A (botulinum toxin A) was found to provide a wide variety of therapeutic and aesthetic benefits as one of the most potent toxins in the world. Injectable remedies, including soft tissue fillers and botulinum toxin, have become very common in wrinkling and face rejuvenation management. While these methods of treatment are relatively safe, serious side effects can occur. In this review, the complications of BoNTA are highlighted.

METHODS:

A literature research considered published journal articles (clinical trials or scientific reviews). Electronic databases (PubMed, Scopus, Science Direct) were searched using key terms, and for identification of additional relevant studies, reference lists have also been examined. Only articles published in English were included in this review with a time restriction from 2000 to 2020.

RESULTS:

There are various injection-related adverse effects associated (AE) with botulinum toxins such as erythema, oedema, pain, ptosis of eyelid or brow and ecchymosis. The overall majority of adverse events identified are mild and temporary.

CONCLUSION:

As the use of toxins becomes increasingly more common, adverse events can be expected to increase as well. The practitioners need to be aware of such AEs, and the patients should be informed of these before undertaking such procedures. LEVEL OF EVIDENCE III This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Envelhecimento da Pele / Toxinas Botulínicas Tipo A Tipo de estudo: Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Envelhecimento da Pele / Toxinas Botulínicas Tipo A Tipo de estudo: Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article